科前生物2024年业绩快报：归母净利润3.75亿元同比降5.27%

财中社2025-02-26

2月26日，科前生物（688526）发布公告，2024年度业绩快报显示，公司营业总收入为9.48亿元，同比减少10.92%；营业利润为4.27亿元，同比减少6.9%；归母净利润为3.75亿元，同比减少5.27%。此外，公司归母净利润在扣除非经常性损益后为3.09亿元，同比减少16.68%。基本每股收益为0.8元，同比下降5.88%。截至2024年末，公司总资产为44.86亿元，较年初减少3.96%...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514881407?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-26 17:19","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514881407","market":"sh","top_or_hot":-1,"title":"科前生物2024年业绩快报：归母净利润3.75亿元 同比降5.27%","media":"财中社","content":"<div>\n<p>2月26日，科前生物（688526）发布公告，2024年度业绩快报显示，公司营业总收入为9.48亿元，同比减少10.92%；营业利润为4.27亿元，同比减少6.9%；归母净利润为3.75亿元，同比减少5.27%。此外，公司归母净利润在扣除非经常性损益后为3.09亿元，同比减少16.68%。基本每股收益为0.8元，同比下降5.88%。截至2024年末，公司总资产为44.86亿元，较年初减少3.96%...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226172642989360f1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科前生物2024年业绩快报：归母净利润3.75亿元 同比降5.27%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科前生物2024年业绩快报：归母净利润3.75亿元 同比降5.27%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-26 17:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226172642989360f1&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月26日，科前生物（688526）发布公告，2024年度业绩快报显示，公司营业总收入为9.48亿元，同比减少10.92%；营业利润为4.27亿元，同比减少6.9%；归母净利润为3.75亿元，同比减少5.27%。此外，公司归母净利润在扣除非经常性损益后为3.09亿元，同比减少16.68%。基本每股收益为0.8元，同比下降5.88%。截至2024年末，公司总资产为44.86亿元，较年初减少3.96%...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226172642989360f1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688526","symbol_name":"科前生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226172642989360f1&s=b","article_id":"2514881407","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226172642989360f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514881407","pubTimestamp":1740561540,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2月26日，科前生物发布公告，2024年度业绩快报显示，公司营业总收入为9.48亿元，同比减少10.92%；营业利润为4.27亿元，同比减少6.9%；归母净利润为3.75亿元，同比减少5.27%。此外，公司归母净利润在扣除非经常性损益后为3.09亿元，同比减少16.68%。基本每股收益为0.8元，同比下降5.88%。截至2024年末，公司总资产为44.86亿元，较年初减少3.96%；归母股东的所有者权益为39.34亿元，较年初增长2.56%。2024年前三季度，科前生物实现收入6.66亿元，归母净利润2.61亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688526":"科前生物"},"translate_title":"Keqian Biotech's 2024 performance report: Net profit attributable to the parent company was 375 million yuan, a year-on-year decrease of 5.27%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688526":1},"content_text":"2月26日，科前生物（688526）发布公告，2024年度业绩快报显示，公司营业总收入为9.48亿元，同比减少10.92%；营业利润为4.27亿元，同比减少6.9%；归母净利润为3.75亿元，同比减少5.27%。此外，公司归母净利润在扣除非经常性损益后为3.09亿元，同比减少16.68%。基本每股收益为0.8元，同比下降5.88%。截至2024年末，公司总资产为44.86亿元，较年初减少3.96%；归母股东的所有者权益为39.34亿元，较年初增长2.56%。公司指出，生猪存栏量的减少以及市场竞争加剧是导致营业收入和净利润下降的主要因素。公司将继续加大研发力度，提升市场竞争力以应对挑战。2024年前三季度，科前生物实现收入6.66亿元，归母净利润2.61亿元。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514881407","isCrawlerRequest":true}

科前生物2024年业绩快报：归母净利润3.75亿元 同比降5.27%

精彩评论

科前生物2024年业绩快报：归母净利润3.75亿元同比降5.27%